Arcus Biosciences, a clinical-stage global biopharmaceutical company, has announced the pricing of an underwritten public offering of 13.7 million shares at a price of $18.25 per...
Researchers at the University of Calgary have developed a new training program aimed at equipping front-line hospital staff with the skills to treat patients with mental...
Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory condition that necessitates immediate medical intervention, especially in its advanced stages. Patients experiencing severe symptoms may require...
Boehringer Ingelheim has secured a license from Kyowa Kirin Co., Ltd. to develop a promising new treatment for autoimmune diseases. The agreement, finalized on October 30,...
CERo Therapeutics, a company specializing in cellular immunotherapy, has received a determination letter from the Nasdaq Hearings Panel denying its request to maintain the listing of...
Dermatique Laser and Skin, a prominent medical spa and laser clinic located in Geneva, celebrated its 20th anniversary on March 15, 2025. Founded by family physician...
Teladoc Health has revised its guidance for net loss per share and revenue for 2025 following a mixed performance in the third quarter of this year....
Ghosts have long fascinated humanity, serving as subjects of folklore and personal anecdotes. These stories often center around the disembodied spirits of deceased individuals, especially those...
Merck and Eisai announced that their late-stage clinical trial assessing the combination of Keytruda and Lenvima, alongside transarterial chemoembolization, has not met one of its primary...
NLS Pharmaceutics has announced a significant corporate move by executing a 1-for-10 reverse share split of its common stock. This decision was made by the company’s...
